Fig. 2From: Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UKOverall survival from 1LOT stratified by key baseline characteristics. a: By regimen; b: By Age; c: By MSKCC score; d: By Diagnosis Year; e: By Histological Subtype (not shown)Back to article page